(Q38086871)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Peptides as the next generation of anti-infectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Deborah A O'Neil

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

Future Medicinal Chemistry

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

315-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

APD2: the updated antimicrobial peptide database and its application in peptide design

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Peptide antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antimicrobial peptides (AMPs): peptide structure and mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Defensins: antimicrobial peptides of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Function and therapeutic potential of host defence peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Emergence and spread of antibiotic resistance following exposure to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

The continuing crisis in antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Origins and evolution of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Cell-penetrating peptides: classes, origin, and current landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Advances in antimicrobial peptide immunobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Quality specifications for peptide drugs: a regulatory-pharmaceutical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Control of cell selectivity of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Development of an ELISA for quantification of the antimicrobial peptide piscidin 4 and its application to assess stress in fish

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Salivary concentration of the antimicrobial peptide LL-37 in children

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Determination of a new antibacterial peptide S-thanatin in rat plasma by an indirected-ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antimicrobial peptides in the duodenum at the acute and convalescent stages in patients with diarrhea due to Vibrio cholerae O1 or enterotoxigenic Escherichia coli infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Novel natural food antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Colistin in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Bacterial resistance mechanisms against host defense peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Daptomycin: a review of properties, clinical use, drug delivery and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antibacterial activities and modes of action of vancomycin and related glycopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Structure, biochemistry and mechanism of action of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Functional and biochemical analysis of a key series of ramoplanin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Role of chemotherapy in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Polymyxins and their novel derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Natural functions of lipopeptides from Bacillus and Pseudomonas: more than surfactants and antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Pediocins: The bacteriocins of Pediococci. Sources, production, properties and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Airway-rehydrating agents for the treatment of cystic fibrosis: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Domain 5 of high molecular weight kininogen is antibacterial

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

The roles of cathelicidin LL-37 in immune defences and novel clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Discovery and development of a synthetic peptide derived from lactoferrin for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

De novo designed synthetic mimics of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Clinical efficacy of a specifically targeted antimicrobial peptide mouth rinse: targeted elimination of Streptococcus mutans and prevention of demineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Cathelicidins and functional analogues as antisepsis molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

An anti-infective peptide that selectively modulates the innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Battle and balance at mucosal surfaces--the story of Shigella and antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Fungicidal effect of three new synthetic cationic peptides against Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antimicrobial properties of derivatives of the cationic tryptophan-rich hexapeptide PAF26.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Concentration-dependent mechanisms of cell penetration and killing by the de novo designed antifungal hexapeptide PAF26.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Sensitivity of Saccharomyces cerevisiae to the cell-penetrating antifungal peptide PAF26 correlates with endogenous nitric oxide (NO) production

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Cationic hydrophobic peptides with antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Diversity of coding sequences and gene structures of the antifungal peptide mytimycin (MytM) from the Mediterranean mussel, Mytilus galloprovincialis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Identification of a novel antifungal peptide with chitin-binding property from marine metagenome

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Fungicidal effect of antimicrobial peptide arenicin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

HP(2-9)-magainin 2(1-12), a synthetic hybrid peptide, exerts its antifungal effect on Candida albicans by damaging the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

A family of bombinin-related peptides from the skin of Bombina variegata

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Bombinins, antimicrobial peptides from Bombina species

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antifungal properties and mode of action of psacotheasin, a novel knottin-type peptide derived from Psacothea hilaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of surgical wound infection with methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Gomesin, a peptide produced by the spider Acanthoscurria gomesiana, is a potent anticryptococcal agent that acts in synergism with fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Biological and structural characterization of new linear gomesin analogues with improved therapeutic indices.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Curvularides A-E: antifungal hybrid peptide-polyketides from the endophytic fungus Curvularia geniculata

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Memories that last forever: strategies for optimizing vaccine T-cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

From optical bench to cageside: intravital microscopy on the long road to rational vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

New paradigms for HIV/AIDS vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Modulation of the immune-related gene responses to protect mice against Japanese encephalitis virus using the antimicrobial peptide, tilapia hepcidin 1-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Peptide inhibitors of viral assembly: a novel route to broad-spectrum antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Multifaceted action of Fuzeon as virus-cell membrane fusion inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Enfuvirtide: from basic investigations to current clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Development of HIV fusion inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Large-scale manufacture of peptide therapeutics by chemical synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Biophysical property and broad anti-HIV activity of albuvirtide, a 3-maleimimidopropionic acid-modified peptide fusion inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

A human claudin-1-derived peptide inhibits hepatitis C virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Identification of the minimal active sequence of an anti-influenza virus peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Inhibition of Ebola virus entry by a C-peptide targeted to endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Peptide inhibition of human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

HSV neutralization by the microbicidal candidate C5A

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Gene expression, antiparasitic activity, and functional evolution of the drosomycin family

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Drosomycin, an essential component of antifungal defence in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Antiparasitic activity of the antimicrobial peptide HbbetaP-1, a member of the beta-haemoglobin peptide family

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

The interaction of an antiparasitic peptide active against African sleeping sickness with cell membrane models

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Novel antimicrobial peptides isolated from skin secretions of the Mexican frog Hyla eximia

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Functional role of charged residues in drosomycin, a Drosophila antifungal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Dermaseptin 01 as antimicrobial peptide with rich biotechnological potential: study of peptide interaction with membranes containing Leishmania amazonensis lipid-rich extract and membrane models

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Analytical characterization of an orally-delivered peptide pharmaceutical product

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.12.213

Empedopeptin (BMY-28117), a new depsipeptide antibiotic. I. Production, isolation and properties.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.37.949

A new anti-MRSA antibiotic complex, WAP-8294A. I. Taxonomy, isolation and biological activities.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.51.929

Identifiers

DOI

10.4155/FMC.12.213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23464521%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference